FDA Inspection 868904 — Brigham And Women's Hospital

Brigham And Women's Hospital — FEI 1270016

The FDA completed an inspection of Brigham And Women's Hospital on March 6, 2014 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 6, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Boston, MA (United States)